« previous next »
Pages: [1]

Author Topic: Medscape MS drug update: Tysabri, ibudilast, daclizumab  (Read 113 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
Medscape MS drug update: Tysabri, ibudilast, daclizumab
« on: March 29, 2018, 02:49:13 pm »
Neurologist Dr. Stephen Krieger gives an update on MS drug research information, touching on the natalizumab dosing schedule change, the potential for ibudilast to treat SPMS, and the withdrawal from the market of daclizumab:


https://www.medscape.com/viewarticle/894238
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
142 Views 		Last post May 29, 2016, 04:39:51 pm
by agate
0 Replies
151 Views 		Last post January 02, 2017, 09:38:13 pm
by agate
0 Replies
117 Views 		Last post June 20, 2017, 03:17:03 pm
by agate
3 Replies
102 Views 		Last post December 18, 2020, 09:47:39 pm
by agate
0 Replies
22 Views 		Last post October 31, 2021, 08:50:16 pm
by agate